JOANN A REED
CIK 1252013 · SVP, Finance and CFO · last filed 2025-05-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$27.49M
Companies
6
Total Filings
72
Lifetime Open-Market Net
-$18.40M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMT | Director | 62,940 | $174.49 | $10.98M | -$3.41M | 28 | 2025-05-16 |
| Keenova Therapeutics plc (MNK) Delisted | Director | 0 | $0.34 | $0 | $17.5K | 14 | 2022-03-21 |
| WAT | Director | 39,685 | $415.84 | $16.50M | -$4.46M | 21 | 2021-03-08 |
| HEALTH MANAGEMENT ASSOCIATES, INC (HMA) Delisted | Director | — | $10.54 | — | $0 | 3 | 2014-01-27 |
| DynaVox Inc. (DVOX) Delisted | Director | 13,336 | — | — | $0 | 2 | 2012-06-04 |
| MEDCO HEALTH SOLUTIONS INC (MHS) Delisted | SVP, Finance and CFO | 167,818 | — | — | -$10.55M | 3 | 2007-09-05 |
Recent Filings · Page 2 of 8
72 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-12 | AMT | Grant (A) | +881 | $0 | EDGAR |
| 2021-03-08 | WAT | Mixed | — | -$203.0K | EDGAR |
| 2021-02-10 | WAT | Mixed | +7,002 | -$1.3K | EDGAR |
| 2021-01-06 | WAT | Grant (A) | +439 | $0 | EDGAR |
| 2020-06-10 | AMT | Sell (S) | −1,950 | -$520.4K | EDGAR |
| 2020-06-01 | WAT | Gift (G) | −352 | $0 | EDGAR |
| 2020-05-15 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −8,729 | -$25.8K | EDGAR |
| 2020-03-12 | AMT | Grant (A) | +739 | $0 | EDGAR |
| 2020-01-03 | WAT | Mixed | +11,273 | -$1.4K | EDGAR |
| 2019-12-05 | AMT | Mixed | +2,763 | -$2.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.